Position history for BlackRock, Inc.'s holdings in REGENERON PHARMACEUTICALS
BlackRock, Inc. holds 8.9M shares of REGN (REGENERON PHARMACEUTICALS), worth $6.9B as of 2026-Q1. The position was increased (+2.4% shares). REGN represents 0.1% of BlackRock, Inc.'s portfolio.
Current Value
$6.9B
Current Shares
8.9M
Total Value Change
+$693.6M
Total Shares Change
+216,113
Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.
Increased |
| 8.9M |
+2.4% |
| $6.9B |
| 0.1% |
| $766.66 |
39 |
| 2025-Q4 | Decreased | 8.7M | -1.1% | $6.7B | 0.1% | $773.94 | 0 |
| 2025-Q3 | Decreased | 8.8M | -4.7% | $5B | 0.1% | $560.05 | 0 |
| 2025-Q2 | Increased | 9.3M | +3.9% | $4.9B | 0.1% | $519.56 | 33 |
| 2025-Q1 | Increased | 8.9M | +2.2% | $5.7B | 0.1% | $634.66 | 39 |
| 2024-Q4 | New | 8.7M | - | $6.2B | 0.1% | $698.71 | 53 |